Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 115, Issue 9, 2008, Pages 1171-1178

  Gomperts, R J ^a   Jelinska, K ^b   Davies, S ^c   Gemzell Danielsson, K ^d   Kleiverda, G ^e  

^a Women on Waves   (Netherlands)

^b Women's Wallet   (Netherlands)

^c Women on Web   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Flevoziekenhuis ^*  (Netherlands)

Author keywords

Abortion; Buccal misoprostol; e health; Home use; Mifepristone; Self administration; Telemedicine

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADOLESCENT; ADULT; ARTICLE; CONSULTATION; DRUG SELF ADMINISTRATION; FEMALE; HEALTH CARE ACCESS; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; ONLINE SYSTEM; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT SAFETY; PREGNANCY TERMINATION; PRIORITY JOURNAL; TELEMEDICINE;

EID: 47349116249     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.01787.x     Document Type: Article

References (8)

1. Grimes DA, Benson J, Singh S, Romero M, Ganatra B, Okonofua FE, et al. Unsafe abortion: the preventable pandemic. Lancet 2006 368 : 1908 19.
2. Fiala C, Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 2006 74 : 66 86.
3. WHO. Frequently asked questions about medical abortion. 2006 www.who.int/reproductive-health/publications/medical_abortion/faq.pdf Accessed 1 March 2007.
4. Blanchard K, Cooper D, Dickson K, Cullingworth L, Mavimbela N, von Mollendorf C, et al. A comparison of women's, providers' and ultrasound assessments of pregnancy duration among termination of pregnancy clients in South Africa. BJOG 2007 114 : 569 75.
5. Fiala C, Winikoff B, Helstrom L, Hellborg M, Gemzell-Danielsson K. Acceptability of home-use of misoprostol in medical abortion. Contraception 2004 70 : 387 92.
6. Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004 103 : 738 45.
7. Faucher P, Baunot N, Madelenat P The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients Gynecol Obstet Fertil 2005 33 : 220 7.
8. Ravn P, Rasmussen A, Knudsen UB, Kristiansen FV. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion. Acta Obstet Gynecol Scand 2005 84 : 1098 102.